Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas
- PMID: 23110010
- PMCID: PMC3479764
- DOI: 10.4132/KoreanJPathol.2012.46.3.246
Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas
Abstract
Background: This study was conducted to clarify the frequency of the BRAF mutation in primary melanomas and its correlation with clinicopathologic parameters.
Methods: We analyzed the frequency of BRAF mutation in patients with primary cutaneous melanoma (n=58) or non-cutaneous one (n=27) by performing dual priming oligonucleotide-based multiplex real-time polymerase chain reaction to isolate and to purify the DNA from the formalin-fixed and paraffin-embedded tumors.
Results: The BRAF mutation was found in 17.2% (10/58) of patients with primary cutaneous melanoma and 11.1% (3/27) of those with non-cutaneous melanoma. The frequency of BRAF mutation was not correlated with any clinicopathologic parameters with the exception of the patient age. The frequency of the BRAF mutation was significantly higher in patients younger than 60 years as compared with those older than 60 years (p=0.005).
Conclusions: Compared with previous reports, our results showed that the frequency of the BRAF mutation was relatively lower in patients with primary cutaneous melanoma. Besides, our results also showed that the frequency of the BRAF mutation had an inverse correlation with the age. Further studies are warranted to exclude methodological bias, to elucidate the difference in the frequency of the BRAF mutation from the previous reports from a Caucasian population and to provide an improved understanding of the molecular pathogenesis of malignant melanoma.
Keywords: BRAF; Frequency; Melanoma; Mutation.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.Ann Dermatol. 2014 Apr;26(2):195-202. doi: 10.5021/ad.2014.26.2.195. Epub 2014 Apr 30. Ann Dermatol. 2014. PMID: 24882974 Free PMC article.
-
Comparison of Three BRAF Mutation Tests in Formalin-Fixed Paraffin Embedded Clinical Samples.Korean J Pathol. 2013 Aug;47(4):348-54. doi: 10.4132/KoreanJPathol.2013.47.4.348. Epub 2013 Aug 26. Korean J Pathol. 2013. PMID: 24009630 Free PMC article.
-
BRAF mutations in conjunctival melanoma.Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2484-8. doi: 10.1167/iovs.04-0093. Invest Ophthalmol Vis Sci. 2004. PMID: 15277467
-
Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.Oncotarget. 2015 Nov 10;6(35):37895-905. doi: 10.18632/oncotarget.5634. Oncotarget. 2015. PMID: 26498143 Free PMC article.
-
Atypical BRAF and NRAS Mutations in Mucosal Melanoma.Cancers (Basel). 2019 Aug 8;11(8):1133. doi: 10.3390/cancers11081133. Cancers (Basel). 2019. PMID: 31398831 Free PMC article. Review.
Cited by
-
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.Oncotarget. 2017 Apr 10;8(32):52304-52320. doi: 10.18632/oncotarget.17014. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881731 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials